Piper Sandler lowered the firm’s price target on CVS Health (CVS) to $99 from $101 and keeps an Overweight rating on the shares. The firm updated its model to better conform with guidance and guidance commentary.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Pharmacy opens first pharmacy-only location in Chicago
- CVS Health call volume above normal and directionally bullish
- Private Markets: OpenAI raises additional $10B funding
- DO sues New York-Presbyterian over allegedly anticompetitive contracts
- Leerink says CVS Health settlement with FTC would remove air of uncertainty